Holdings of NOVO HOLDINGS A/S
19 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 79.3 % of the equity sleeve
Sector breakdown
- Technology 19.6 %
- Consumer discretionary 3.2 %
- Unattributed 77.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 87.0 %
- NL 12.4 %
- FR 0.7 %
Shares computed on the equity sleeve.
| Country | Lines | Value | Share |
|---|---|---|---|
| US | 17 | 883M $ | 86.99 % |
| NL | 1 | 125.4M $ | 12.35 % |
| FR | 1 | 6.6M $ | 0.65 % |
Positions
| Company | Shares | Value | Weight |
|---|---|---|---|
| Edgewise Therapeutics Inc | 5,350,000 | 168.5M $ | |
| ASML Holding NV | 94,946 | 125.4M $ | |
| Mirum Pharmaceuticals Inc | 1,325,000 | 122.4M $ | |
| MapLight Therapeutics Inc | 3,686,622 | 74.9M $ | |
| Salesforce Inc | 393,187 | 73.4M $ | |
| Crinetics Pharmaceuticals Inc | 1,550,000 | 56.3M $ | |
| Enliven Therapeutics Inc | 1,280,000 | 50.2M $ | |
| Vaxcyte Inc | 860,000 | 50M $ | |
| ArriVent Biopharma Inc | 1,942,142 | 44.8M $ | |
| Viridian Therapeutics Inc | 2,000,000 | 39.1M $ | |
| Celldex Therapeutics Inc | 1,200,000 | 38.1M $ | |
| Apogee Therapeutics Inc | 450,000 | 37.9M $ | |
| BioMarin Pharmaceutical Inc | 660,000 | 37.3M $ | |
| 4D Molecular Therapeutics Inc | 3,650,737 | 34M $ | |
| Alibaba Group Holding Ltd | 257,327 | 32.3M $ | |
| BridgeBio Oncology Therapeutics Inc | 2,185,923 | 19.6M $ | |
| VALNEVA SE | 1,057,421 | 6.6M $ | |
| LANZATECH GLOBAL INC | 158,148 | 2.5M $ | |
| Marqeta Inc | 441,558 | 1.8M $ |